An Observational Comparative Study of the Effect of Sepsis on Serum CPeptide and Insulin Levels in Patients with Type 2 Diabetes Mellitus
Authors/Creators
- 1. 3rd Yr Resident, Department of General Medicine, SMS Medical College, Jaipur
- 2. Associate Professor, Department of General Medicine, SMS Medical College, Jaipur
- 3. Second Year Resident, Department of General Medicine, SMS Medical College, Jaipur
- 4. Assistant Professor, Department of General Medicine, SMS Medical College, Jaipur
- 5. Senior Professor, Department of General Medicine, SMS Medical College, Jaipur
Description
Introduction: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance and a relative deficiency in insulin secretion. Patients with T2DM are more susceptible to infections and sepsis due to the immunocompromised state associated with chronic hyperglycemia. The interplay between C-peptide, insulin, and HbA1c levels during sepsis requires careful monitoring and management to optimize glycaemic control and improve patient outcomes. Understanding these dynamics is crucial for effectively managing T2DM patient. Aim: To assess serum c-peptide and insulin levels in type 2 diabetes with or without sepsis. Material and Methods: This observational comparative study, conducted at SMS Medical College, Jaipur, included 180 participants divided into three groups: diabetic patients with sepsis (Group A), diabetic patients without sepsis (Group B), and non-diabetic patients with sepsis (Group C). Each group underwent clinical evaluation and laboratory investigations, including C-peptide, insulin levels, CBC, and SOFA score, with sepsis diagnosed using Sepsis-3 criteria. Data were analyzed to compare organ dysfunction and inflammatory responses across groups. Results: Our study shows that sepsis elevates both C-peptide and insulin levels, with a more pronounced increase in C-peptide, particularly in diabetic patients, reflecting its immune-modulating role. Additionally, sepsis significantly impacts platelet counts, GCS scores, SOFA scores, albumin levels, and TLC, emphasizing its systemic effects. Conclusion: Our findings demonstrate that sepsis enhances pancreatic activity, as shown by increased C peptide and insulin levels, but this response is influenced by the presence of diabetes. Thus, C peptide serves as a valuable marker for assessing pancreatic function in the context of sepsis, highlighting the complex interplay between diabetes and sepsis on pancreatic and insulin dynamics.
Abstract (English)
Introduction: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance and a relative deficiency in insulin secretion. Patients with T2DM are more susceptible to infections and sepsis due to the immunocompromised state associated with chronic hyperglycemia. The interplay between C-peptide, insulin, and HbA1c levels during sepsis requires careful monitoring and management to optimize glycaemic control and improve patient outcomes. Understanding these dynamics is crucial for effectively managing T2DM patient. Aim: To assess serum c-peptide and insulin levels in type 2 diabetes with or without sepsis. Material and Methods: This observational comparative study, conducted at SMS Medical College, Jaipur, included 180 participants divided into three groups: diabetic patients with sepsis (Group A), diabetic patients without sepsis (Group B), and non-diabetic patients with sepsis (Group C). Each group underwent clinical evaluation and laboratory investigations, including C-peptide, insulin levels, CBC, and SOFA score, with sepsis diagnosed using Sepsis-3 criteria. Data were analyzed to compare organ dysfunction and inflammatory responses across groups. Results: Our study shows that sepsis elevates both C-peptide and insulin levels, with a more pronounced increase in C-peptide, particularly in diabetic patients, reflecting its immune-modulating role. Additionally, sepsis significantly impacts platelet counts, GCS scores, SOFA scores, albumin levels, and TLC, emphasizing its systemic effects. Conclusion: Our findings demonstrate that sepsis enhances pancreatic activity, as shown by increased C peptide and insulin levels, but this response is influenced by the presence of diabetes. Thus, C peptide serves as a valuable marker for assessing pancreatic function in the context of sepsis, highlighting the complex interplay between diabetes and sepsis on pancreatic and insulin dynamics.
Files
IJPCR,Vol16,Issue12,Article67.pdf
Files
(407.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:af7f4eb3592a82f723a03911ac7df263
|
407.5 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-12-11
Software
- Repository URL
- http://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue12,Article67.pdf
- Development Status
- Active
References
- 1. Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels, Belgium: International Diabetes Federation; 2019. 2. Kramer A, Conlon M, Cox C, Hsu R, Redding J, Wisniewski SR. The interaction between sepsis and diabetes mellitus: Current evidence and practical considerations. Crit Care Med. 2015;43(12):2622-30. doi:103. Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the diagnosis and management of diabetes. Diabet Med. 2013;30(7):743-50. doi:10.1111/dme.12115. 4. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17) Anjana, Ranjit MohanMohan, Viswanathan et al.The Lancet Diabetes & Endocrinology, Volume 11, Issue 7, 474 – 489 5. Crisman M, Lucchetta L, Luethi N, Cioccari L, Lam Q, Eastwood GM, Bellomo R, Mårtensson J. The effect of insulin administration on c-peptide in critically ill patients with type 2 diabetes. Ann Intensive Care. 2017 Dec;7(1):50. 6. Chávez-Reyes J, Escárcega-González CE, Chavira-Suárez E, León-Buitimea A, VázquezLeón P, Morones-Ramírez JR, Villalón CM, Quintanar-Stephano A, 7. Marichal-Cancino BA. Susceptibility for Some Infectious Diseases in Patients with Diabetes: The Key Role of Glycemia. Front Public Health. 2021 Feb 16; 9:559595. 8. Cheng J, Zeng H, Chen H, Fan L, Xu C, Huang H, Tang T, Li M. Current knowledge of thrombocytopenia in sepsis and COVID-19. Front Immunol. 2023 Sep 28; 14:1213510. 9. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. 10.1001/jama.2016.0287. PMID: 26903338; PMCID: PMC4968574. 10. Karakike, E., Kyriazopoulou, E., Tsangaris, I. et al. The early change of SOFA score as a prognostic marker of 28-day sepsis mortality: analysis through a derivation and a validation cohort. Crit Care 23, 387 (2019 11. Gupta L. Hpoalbuminemia as a prognostic factor in sepsis, severe sepsis and septic shock. Critical Care Medicine 40(12): p 1-328, December 2012. 12. Li Q, Xie J, Huang Y, Liu S, Guo F, Liu L, Yang Y. Leukocyte kinetics during the early-stage acts as a prognostic marker in patients with septic shock in intensive care unit. Medicine (Baltimore). 2021 Jun 11;100(23):e26288 13. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 Nov 8;345(19):1359-67. doi: 10.1056/NEJMoa011300. PMID: 11794168.